RxSight, Inc. (NASDAQ:RXST – Get Free Report) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totalling 1,060,000 shares, a decline of 24.8% from the August 31st total of 1,410,000 shares. Based on an average daily volume of 462,600 shares, the short-interest ratio is […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 1,060,000 shares, a drop of 24.8% from the August 31st total of 1,410,000 shares. Approximately 3.8% of the company’s shares are short sold. Based […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report)’s share price traded up 3.9% during trading on Wednesday . The company traded as high as $28.79 and last traded at $28.77. 145,151 shares traded hands during mid-day trading, a decline of 56% from the average session volume of 329,425 shares. The stock had previously closed at $27.69. […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Bakker Juliet Tammenoms sold 2,950 shares of RxSight stock in a transaction on Monday, September 11th. The stock was sold at an average price of $30.01, for a total value of $88,529.50. Following the sale, the director now owns 20,223 shares in the company, valued at $606,892.23. […]